1. A Comparative Analysis of CPA1, bcl10 and Chymotrypsin for the Distinction of Pancreatic Acinar Cell Carcinomas. (9th November 2022) Authors: Uhlig, R; Minner, S; Luebke, A; Weidemann, S; Lebok, P; Gorbokon, N; Blessin, N C; Lennartz, M; Sauter, G; Jacobsen, F; Clauditz, T S Journal: American journal of clinical pathology Issue: Volume 158(2022)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Automated prognosis marker assessment in 2, 004 breast cancers using an artificial intelligence-based framework for BLEACH&STAIN multiplex fluorescence immunohistochemistry. (9th November 2022) Authors: Mandelkow, T; Bady, E; Müller, J; Debatin, N F; Lurati, M C; Lennartz, M; Sauter, G; Blessin, N C Journal: American journal of clinical pathology Issue: Volume 158(2022)Supplement 1 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Automated Prostate Cancer Identification Facilitates Prognosis Marker Assessment in 11, 845 Prostate Cancers Using Artificial Intelligence and BLEACH&STAIN Multiplex Fluorescence Immunohistochemistry. (9th November 2022) Authors: Blessin, N C; Müller, J; Mandelkow, T; Bady, E; Lurati, M C; Lennartz, M; Graefen, M; Sauter, G; Steurer, S Journal: American journal of clinical pathology Issue: Volume 158(2022)Supplement 1 Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cadherin-16 (CDH16) Immunohistochemistry: A Novel Diagnostic Tool for Renal Cell Carcinoma and Papillary Carcinomas of the Thyroid. (9th November 2022) Authors: Lennartz, M; Minner, S; Gorbokon, N; Menz, A; Krech, T; Höflmayer, D; Simon, R; Blessin, N C; Sauter, G; Clauditz, T S; Hinsch, A Journal: American journal of clinical pathology Issue: Volume 158(2022)Supplement 1 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P03.01 Prevalence of CD112R+immune cells in normal lymphatic tissues, inflammation and the cancer microenvironment. (1st October 2020) Authors: Blessin, NC; Mandelkow, T; Bady, E; Hube-Magg, C; Simon, R; Sauter, G; Fraune, C; Lennartz, M; Möller, K; Höflmayer, D; Weidemann, SA Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P03.06 Pattern of Ki67+expanding CD8+cytotoxic T cells in healthy tissues, inflammation and the cancer microenvironment. (1st October 2020) Authors: Möller, K; Lennartz, M; Abu-Hashem, R; Blessin, NC; Mandelkow, T; Bady, E; Hube-Magg, C; Simon, R; Sauter, G; Fraune, C; Clauditz, TS; Büscheck, F; Luebke, AM Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P03.10 Prevalence and prognostic role of FoxP3+regulatory T lymphocytes in cancer. A tissue microarray study on >20'000 cancers. (1st October 2020) Authors: Mandelkow, T; Bady, E; Blessin, NC; Hube-Magg, C; Simon, R; Sauter, G; Fraune, C; Lennartz, M; Möller, K; Weidemann, SA; Luebke, AM; Höflmayer, D; Büscheck, F Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence. (28th October 2021) Authors: Dum, D; Blessin, N C; Henke, T L; Mandelkow, T; Bady, E; Raedler, J; Simon, R; Sauter, G; Lennartz, M; Wilczak, W; Burandt, E Journal: American journal of clinical pathology Issue: Volume 156(2021)Supplement 1 Page Start: S137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗